These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3668385)

  • 21. Identification of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,24,25,26-hexol in human urine.
    Hiraoka T; Kihira K; Kajiyama G; Kuramoto T; Hoshita T
    J Lipid Res; 1987 Aug; 28(8):895-9. PubMed ID: 3668388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial giant cell hepatitis with low bile acid concentrations and increased urinary excretion of specific bile alcohols: a new inborn error of bile acid synthesis?
    Clayton PT; Casteels M; Mieli-Vergani G; Lawson AM
    Pediatr Res; 1995 Apr; 37(4 Pt 1):424-31. PubMed ID: 7596681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
    Batta AK; Salen G; Tint GS
    Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased urinary excretion of bile alcohol glucuronides in patients with primary biliary cirrhosis.
    Weydert-Huijghebaert S; Karlaganis G; Renner EL; Preisig R
    J Lipid Res; 1989 Nov; 30(11):1673-9. PubMed ID: 2614269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment.
    Koopman BJ; Wolthers BG; van der Molen JC; Nagel GT; Waterreus RJ; Oosterhuis HJ
    Clin Chim Acta; 1984 Sep; 142(1):103-11. PubMed ID: 6478619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of positive ion fast atom bombardment mass spectrometry for rapid identification of a bile alcohol glucuronide isolated from cerebrotendinous xanthomatosis patients.
    Dayal B; Salen G; Tint GS; Shefer S; Benz SW
    Steroids; 1990 Feb; 55(2):74-8. PubMed ID: 2183402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of new bile alcohols, 5 beta-cholestane-3 alpha,7 alpha,24,26-tetrol, 5 beta-cholestane-3 alpha,7 alpha,25,26-tetrol, and 5 beta-cholestane-3 alpha,7 alpha,26,27-tetrol in human gallbladder bile.
    Une M; Shinonaga Y; Matoba N; Kuroki S; Kihira K; Hoshita T
    J Lipid Res; 1986 Dec; 27(12):1318-23. PubMed ID: 3559394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of bile alcohols in rat bile.
    Hiraoka T; Kohda T; Kosaka D; Yamauchi T; Kihira K; Kuramoto T; Hoshita T; Kajiyama G
    J Lipid Res; 1989 Dec; 30(12):1889-93. PubMed ID: 2621416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
    Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
    J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stable isotope dilution assay for 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol and 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in human serum using [26,27-D6] labeled internal standards; a highly accurate approach to the serological diagnosis of cerebrotendinous xanthomatosis.
    Kosaka D; Hiraoka T; Kohoda T; Kajiyama G; Yamauchi T; Kihira K; Kuramoto T; Hoshita T
    Clin Chim Acta; 1991 May; 199(1):83-9. PubMed ID: 1934504
    [No Abstract]   [Full Text] [Related]  

  • 31. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
    J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis.
    Nakamura T; Matsuzawa Y; Takemura K; Kubo M; Miki H; Tarui S
    Metabolism; 1991 Jul; 40(7):741-6. PubMed ID: 1908036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of bile alcohols, 24-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,24-tetrol and 3 alpha,7 alpha,12 alpha-trihydroxy-26,27-dinor-5 beta-cholestan-24-one, in rats.
    Kibe A; Fukura M; Kihira K; Kuramoto T; Hoshita T
    J Biochem; 1981 Feb; 89(2):369-77. PubMed ID: 7240118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inborn errors of bile acid metabolism.
    Clayton PT
    J Inherit Metab Dis; 1991; 14(4):478-96. PubMed ID: 1749214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile acids and bile alcohols in a child with hepatic 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency: effects of chenodeoxycholic acid treatment.
    Ichimiya H; Egestad B; Nazer H; Baginski ES; Clayton PT; Sjövall J
    J Lipid Res; 1991 May; 32(5):829-41. PubMed ID: 2072042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of bile alcohols in urine from healthy humans.
    Kuwabara M; Ushiroguchi T; Kihira K; Kuramoto T; Hoshita T
    J Lipid Res; 1984 Apr; 25(4):361-8. PubMed ID: 6726087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of pentahydroxy bile alcohols in cerebrotendinous xanthomatosis: characterization of 5beta-cholestane-3alpha, 7alpha, 12alpha, 24xi, 25-pentol and 5beta-cholestane-3alpha, 7alpha, 12alpha, 23xi, 25-pentol.
    Shefer S; Dayal B; Tint GS; Salen G; Mosbach EH
    J Lipid Res; 1975 Jul; 16(4):280-6. PubMed ID: 1141769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis.
    Dayal B; Tint GS; Greeley DN; Williams TH; Salen G
    Steroids; 1983 Oct; 42(4):441-8. PubMed ID: 6679948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
    Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
    J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Configurational assignment of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23, 25-pentol excreted by patients with cerebrotendinous xanthomatosis (a circular dichroism study).
    Dayal B; Tint GS; Shefer S; Salen G
    Steroids; 1979 Mar; 33(3):327-38. PubMed ID: 442127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.